Kohji Fukunaga

20PUBLICATIONS
30CO-AUTHORS
PharmacogenomicsClinical pharmacology and therapeuticsMolecular targetsNeurology and neuromuscular diseasesAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 29, 2026
Dopamine D2 Receptors, D1/D2 Receptor Heteromers and CaMKII Signaling in the Neurobiology of Drug Addiction.

|Dec 09, 2023
Pathogenic Impact of Fatty Acid-Binding Proteins in Parkinson's Disease-Potential Biomarkers and Therapeutic Targets.

Ichiro Kawahata, Kohji Fukunaga

|Apr 13, 2023
Amelioration of Nicotine-Induced Conditioned Place Preference Behaviors in Mice by an FABP3 Inhibitor.

Wenbin Jia, Ichiro Kawahata, An Cheng

|Sep 09, 2022
Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets.

Qingyun Guo, Ichiro Kawahata, An Cheng

|Jun 10, 2022
Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies.

Ichiro Kawahata, David I Finkelstein, Kohji Fukunaga

|Jul 02, 2021
T-Type Ca2+ Enhancer SAK3 Activates CaMKII and Proteasome Activities in Lewy Body Dementia Mice Model.

Jing Xu, Ichiro Kawahata, Hisanao Izumi

Pageof 4

Frequent Collaborators

12 joint publications

Ichiro Kawahata

5 joint publications

An Cheng

3 joint publications

Wenbin Jia

2 joint publications

Yasuharu Shinoda